180 related articles for article (PubMed ID: 15329109)
1. Histopathological and immunohistochemical study of papillary urothelial neoplasms of low malignant potential and grade associated with extensive invasive low-grade urothelial carcinoma.
Mai KT; Elmontaser G; Perkins DG; Yazdi HM; Stinson WA; Thijssen A
BJU Int; 2004 Sep; 94(4):544-7. PubMed ID: 15329109
[TBL] [Abstract][Full Text] [Related]
2. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder.
Pich A; Chiusa L; Formiconi A; Galliano D; Bortolin P; Comino A; Navone R
Cancer; 2002 Aug; 95(4):784-90. PubMed ID: 12209722
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin cell-adhesion molecule expression as a diagnostic adjunct in urothelial cytology.
Ross JS; Cheung C; Sheehan C; del Rosario AD; Bui HX; Fisher HA
Diagn Cytopathol; 1996 Jun; 14(4):310-5. PubMed ID: 8725130
[TBL] [Abstract][Full Text] [Related]
5. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
Coblentz TR; Mills SE; Theodorescu D
Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
[TBL] [Abstract][Full Text] [Related]
6. Papillary urothelial neoplasms of low malignant potential. Clinical and biologic implications.
Cheng L; Neumann RM; Bostwick DG
Cancer; 1999 Nov; 86(10):2102-8. PubMed ID: 10570438
[TBL] [Abstract][Full Text] [Related]
7. Benign and low-grade papillary lesions of the urinary bladder: a review of the papilloma-papillary carcinoma controversy, and a report of five typical papillomas.
Eble JN; Young RH
Semin Diagn Pathol; 1989 Nov; 6(4):351-71. PubMed ID: 2692107
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty-eight spindle cell neoplasms.
Iczkowski KA; Shanks JH; Gadaleanu V; Cheng L; Jones EC; Neumann R; Nascimento AG; Bostwick DG
Mod Pathol; 2001 Oct; 14(10):1043-51. PubMed ID: 11598176
[TBL] [Abstract][Full Text] [Related]
9. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia.
Desai S; Lim SD; Jimenez RE; Chun T; Keane TE; McKenney JK; Zavala-Pompa A; Cohen C; Young RH; Amin MB
Mod Pathol; 2000 Dec; 13(12):1315-23. PubMed ID: 11144928
[TBL] [Abstract][Full Text] [Related]
10. [An unusual variant of urothelial carcinoma: the "nested variant of urothelial carcinoma." Report of two cases].
Badoual C; Bergemer-Fouquet AM; Renjard L; Lefrancq T; Lesourd B; Belhiba H; Fetissof F; Vieillefond A
Ann Pathol; 1999 Apr; 19(2):119-23. PubMed ID: 10349476
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of bladder wash cytology, with special reference to low grade urothelial neoplasms.
Sack MJ; Artymyshyn RL; Tomaszewski JE; Gupta PK
Acta Cytol; 1995; 39(2):187-94. PubMed ID: 7887066
[TBL] [Abstract][Full Text] [Related]
12. Urothelial papilloma of the bladder. Clinical and biologic implications.
Cheng L; Darson M; Cheville JC; Neumann RM; Zincke H; Nehra A; Bostwick DG
Cancer; 1999 Nov; 86(10):2098-101. PubMed ID: 10570437
[TBL] [Abstract][Full Text] [Related]
13. Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation.
Zhang ZT; Pak J; Huang HY; Shapiro E; Sun TT; Pellicer A; Wu XR
Oncogene; 2001 Apr; 20(16):1973-80. PubMed ID: 11360181
[TBL] [Abstract][Full Text] [Related]
14. Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder.
Cina SJ; Epstein JI; Endrizzi JM; Harmon WJ; Seay TM; Schoenberg MP
Hum Pathol; 2001 Jun; 32(6):630-7. PubMed ID: 11431718
[TBL] [Abstract][Full Text] [Related]
15. [Spectrum of morphologic findings in cystectomy specimens].
Savvas V; Presse S; Kuntz RM
Verh Dtsch Ges Pathol; 1993; 77():266-70. PubMed ID: 7511295
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of denuded urothelium in bladder biopsy.
Levi AW; Potter SR; Schoenberg MP; Epstein JI
J Urol; 2001 Aug; 166(2):457-60. PubMed ID: 11458047
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
Genega EM; Hutchinson B; Reuter VE; Gaudin PB
Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of atypical papillary urothelial hyperplasia.
Swierczynski SL; Epstein JI
Hum Pathol; 2002 May; 33(5):512-7. PubMed ID: 12094376
[TBL] [Abstract][Full Text] [Related]
19. Stromal and vascular invasion in an human in vitro bladder cancer model.
Booth C; Harnden P; Trejdosiewicz LK; Scriven S; Selby PJ; Southgate J
Lab Invest; 1997 Jun; 76(6):843-57. PubMed ID: 9194860
[TBL] [Abstract][Full Text] [Related]
20. Urothelial carcinoma of the prostate.
Goebbels R; Amberger L; Wernert N; Dhom G
Appl Pathol; 1985; 3(4):242-54. PubMed ID: 3842265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
